Secoisolariciresinol Diglucoside

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameSecoisolariciresinol Diglucoside
Drug Alias NameSDG
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-activating factor inhibitors
TargetsPlatelet-activating factor
Therapy Area/IndicationsHealthy AgingPainInflammation +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Saskatchewan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHealthy AgingPainInflammation +[7

Other Information

ATC CodeN/A
Related LinksWikipedia